Home Beacon Biosignals

Beacon Biosignals

In operation
Series B
Developer of AI Platform for Neurological and Psychiatric Disorders Treatment

Basic Information

Beacon's EEG Neurobiomarker Platform is designed to accelerate clinical trials and provide new treatment options for patients with neurological and psychiatric disorders. Through advanced machine learning algorithms, extensive datasets, and progress in software engineering, we are transforming the way patients address brain-related diseases.
Beacon Biosignals, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2019
--